Personal Statement: I’m fully trained in all Diagnostic imaging modalities including X-ray, Mammography, Fluoroscopy, OB/GYN and General Ultrasound, CT scan and MRI. I’m also a board certified Nuclear Medicine physician with vast experience on, General Nuclear Medicine, Cardiac SPECT, SPECT/CT, PET/CT and Radionuclide therapy. I’m comfortable performing basic imaging guided interventional procedures such as biopsies, drainages, central line placements, etc.
MEDICAL EDUCATION
1. Residency in Diagnostic Radiology – University of Miami / Jackson Memorial Hospital,
Dates: 07/01/2010 to 06/30/2013 (Completion date)
2. Chief Resident in Nuclear Medicine – University of Miami / Jackson Memorial Hospital,
Dates: 7/01/2009 to 06/30/2010
3. Residency in Nuclear Medicine – University of Miami / Jackson Memorial Hospital,
Dates: 07/01/2007 to 06/30/2010
4. Internship in Internal Medicine– University of Miami / Jackson Memorial Hospital,
Dates: 06/24/2006 to 06/23/2007
5. Medical Degree - Universidade Federal da Bahia – Brazil - College of Medicine,
Dates: 02/01/1999 to 01/21/2005
BOARD CERTIFICATION
1. American Board of Radiology - Board Eligible At completion of Residency
2. American Board of Nuclear Medicine #7941 Date: 10/08/2010
3. Educational Commission for Foreign Medical Graduates – ECFMG
Certificate Number: 0-665-002-2 Date: 09/27/2005
4. United State Medical License Examination – USMLE
USMLE - Step 1 Date: 05/08/2004
USMLE – Step 2 Clinical Knowledge Date: 11/20/2004
USMLE – Step 2 Clinical Skills: PASSED Date: 06/16/2005
USMLE – Step 3 Date: 02/06/2006
MEDICAL LICENSURE
1. Florida-Full Medical License
License Expiration Date: 1/31/2014 License Original Issue Date: 04/01/2010
LANGUAGES:
• English, Portuguese and Spanish.
ORIGINAL PEER-REVIEWED ARTICLES
1. Radiopharmaceuticals: when and how to use them to treat metastatic bone pain. Paes FM, Ernani V, Hosein P, Serafini AN. J Support Oncol. 2011 Nov-Dec;9(6):197-205.
2. Utility of positron emission tomography scans in mantle cell lymphoma. Hosein PJ, Pastorini VH, Paes FM, Eber D, Chapman JR, Serafini AN, Alizadeh AA, Lossos IS. Am J Hematol. 2011 Oct;86(10):841-5.
3. F-18 FDG PET positive hilar and mediastinal lymphadenopathy mimicking metastatic disease in a melanoma patient treated with interferon-alpha-2b. Kalkanis D, Kalkanis A, Gomaa O, Paes FM, Sfakianakis GN. Clin Nucl Med. 2011 Feb;36(2):154-5.
4. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain.
Paes FM, Serafini AN. Semin Nucl Med. 2010 Mar;40(2):89-104.
5. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease.
Paes FM, Kalkanis DG, Sideras PA, Serafini AN. Radiographics. 2010 Jan-Feb;30(1):269-91.
6. Interesting image. FDG-PET/CT in primary large B-cell lymphoma of the hard palate.
Kalkanis D, Kalkani M, Gomes H, Paes FM, Sideras P, Sfakianakis GN. Clin Nucl Med. 2010 Jan;35(1):24-5.
7. [18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.
Kalkanis D, Stefanovic A, Paes FM, Escalon MP, Serafini A, Lossos IS. Leuk Lymphoma. 2009 Jun;50(6):904-11
8. Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis.
Vinhas V, Andrade BB, Paes F, Bomura A, Clarencio J, Miranda JC, Báfica A, Barral A, Barral-Netto M. Eur J Immunol. 2007 Nov;37(11):3111-21.
9. The sodium-iodine symporter and the proton-pump inhibitors in - related to the side effects of- the treatment of thyroid cancer with iodine-131.
Sfakianakis G, Sfakianaki E. (Acknowledged) Hell J Nucl Med. 2007 Jan-Apr;10(1):2-5.
10. Peripheral Arterial Disease of The Lower Limbs at Public Hospitals of Salvador, Patients and Medical Care, Nunes, JLB; Neto, AMS; Andrade, CS; Duque, BC; Costa, FPM; Paes, FM; Santos, ESS; Filho, JSA, J Vasc Bras 2002 , Volume: 1, Pages: 201-2006.
POSTER PRESENTATIONS - ABSTRACTS
1. Paes FM, Kalkanis D, Serafini AN. Beyond Metastasis Detection: The Utility of Tc99-MDP Bone SPECT/CT Scan. Radiological Society of North America - 97th Scientific Assembly and Annual Meeting; Chicago, IL. Nov 2011
2. Paes FM, Hosein P, Pastorini V, Kalkanis D, Serafini AN. Prognostic Utility of Diagnostic Positron Emission Tomography Scans in Mantle Cell Lymphoma. Radiological Society of North America - 97th Scientific Assembly and Annual Meeting; Chicago, IL. Nov 2011
1. Paes FM, Kalkanis D, Gomaa O, Serafini AN. Spectrum of Tc99m-HDP SPECT/CT findings in benign and malignant bone conditions: Additional or redundant information?
J. NUCL. Med. MEETING ABSTRACTS, May 2010; 51: 1064.
2. Kalkanis D, Paes FM, Gomaa O and Serafini AN. 18F-FDG PET/CT findings of perineural involvement in head and neck malignancies. J. NUCL. Med. MEETING ABSTRACTS, May 2010; 51: 1092.
3. Kalkanis D, Paes FM, Gomaa O, Sfakianakis G and Serafini SN. Diagnostic accuracy of 18F-FDG PET/CT in restaging cervical carcinoma after first-line treatment. J. NUCL. Med. MEETING ABSTRACTS, May 2010; 51: 1223.
4. Paes FM, Goldstein L, McCartney S and Martinez H. Expected and Unexpected Radiographic Findings in Patients after Cardiac Surgery. Association of University Radiology 57th Annual Meeting, May 12-15, 2009, Arlington, Virginia.
5. Paes FM, Thota S, Kardon R, Ghersin E, Seigel Y and Fishman J. Cardiac Magnetic Resonance (CMR) evaluation of repaired Tetralogy of Fallot: Techniques, findings and prognosis. American Roentgen Ray Society (ARRS) Annual Meeting, April 26 - 30, 2009; Boston, Massachusetts.
6. Paes FM, Braga TA, Gomes H, Serafini AN. 18F FDG-PET/CT of atherosclerotic disease - Imaging the vulnerable plaque: A literature and pictorial review. Radiological Society of North America - 94th Scient...
Login or Register to view the full resume.
